Langconoy, Wilfredo L.
HRN: 21-51-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/30/2022
07/07/2022
IV INFUSION
4.5g
Q6
Increasing WBC Trend; Pustular Discharges; Pulmonary Infiltrates
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes